Diabetes drug metformin tested as Anti-Aging treatment in prediabetic indians
NCT ID NCT07302932
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether metformin, a drug used for diabetes, can affect signs of aging in people with prediabetes. Researchers measured changes in telomere length and activity of longevity-related genes in 112 North Indian adults over six months. The goal was to see if metformin might slow aging at a cellular level, not to treat or cure any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METFORMIN, PREDIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anoop misra
New Delhi, National Capital Territory of Delhi, 110048, India